Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wael A. R. A. Hassan"'
Autor:
Masaya Iwamuro M.D., Toshiyuki Komaki, Yasuhiro Kubota, Masayuki Seita, Hironobu Kawamoto, Takeshi Yuasa, Javed M. Shahid, Reham A. R. A. Hassan, Wael A. R. A. Hassan, Shuhei Nakaji, Yuriko Nishikawa, Eisaku Kondo, Kazuhide Yamamoto, Naoya Kobayashi
Publikováno v:
Cell Transplantation, Vol 19 (2010)
Definitive endoderm (DE) derived from stem cells holds potential to differentiate into hepatocytes. Stem cell therapy using those cells has potential for a treatment of liver disease. To date, various ways of inducing hepatocytes from embryonic stem
Externí odkaz:
https://doaj.org/article/728d971d68134f2784a665dd594abd17
Autor:
Masaya Iwamuro M.D., Toshiyuki Komaki, Yasuhiro Kubota, Masayuki Seita, Hironobu Kawamoto, Takeshi Yuasa, Javed M. Shahid, Reham A. R. A. Hassan, Wael A. R. A. Hassan, Shuhei Nakaji, Yuriko Nishikawa, Eisaku Kondo, Kazuhide Yamamoto, Ira J. Fox, Naoya Kobayashi
Publikováno v:
Cell Transplantation, Vol 19 (2010)
Induced pluripotent stem (iPS) cells are pluripotent and are able to unlimitedly proliferate in vitro. This technical breakthrough in creating iPS cells from somatic cells has noteworthy implications for overcoming the immunological rejection and the
Externí odkaz:
https://doaj.org/article/c42b7eed81ba4f0799cd41e02b046924
Autor:
Yasuhiro Kubota, Masayuki Seita, Shinichi Matsumoto, Naoya Kobayashi, Shuhei Nakaji, Noriaki Tanaka, Eisaku Kondo, Shahid M. Javed, Hirofumi Noguchi, Reham A. R. A. Hassan, Alejandro Soto-Gutierrez, Hironobu Kawamoto, Takeshi Yuasa, Takahiro Hayashi, Hiroyuki Nakahara, Wael A. R. A. Hassan, Nalu Navarro-Alvarez, Yuriko Nishikawa
Publikováno v:
Cell Transplantation, Vol 19 (2010)
It has been proposed in human colorectal cancers (CRC) a minority subset of cancer cells within tumors able to initiate tumor growth, defined as cancer stem cells (CSC). Solid human primary colonic and its ovarian metastatic cancer tissues were colle
Autor:
Hiroyuki Nakahara, Yuichi Tashiro, Yasuhiro Kubota, Hirosuke Endo, Eisaku Kondo, Naoya Kobayashi, Toshifumi Ozaki, Masato Tanaka, Reham A. R. A. Hassan, Haruo Misawa, Shahid M. Javed, Hirofumi Noguchi, Katsuyoshi Takata, Takeshi Yuasa, Masayuki Seita, Hironobu Kawamoto, Takahiro Hayashi, Shinichi Matsumoto, Wael A. R. A. Hassan, Shuhei Nakaji
Publikováno v:
Transplantation. 88:346-353
Background Human mesenchymal stem cells (hMSCs) are multipotent stem cells found in the adult bone marrow that have the capacity to differentiate into various mesenchymal cell types. The hMSCs may provide a potential therapy to restore damaged tissue
Autor:
Toshiyuki Komaki, Masayuki Seita, Naoya Kobayashi, Eisaku Kondo, Yuriko Nishikawa, Masaya Iwamuro, Reham A. R. A. Hassan, Wael A. R. A. Hassan, Takeshi Yuasa, Javed M. Shahid, Yasuhiro Kubota, Hironobu Kawamoto, Shuhei Nakaji, Ira J. Fox, Kazuhide Yamamoto
Publikováno v:
Cell Transplantation, Vol 19 (2010)
Induced pluripotent stem (iPS) cells are pluripotent and are able to unlimitedly proliferate in vitro. This technical breakthrough in creating iPS cells from somatic cells has noteworthy implications for overcoming the immunological rejection and the
Autor:
Javed M. Shahid, Masaya Iwamuro, Yasuhiro Kubota, Reham A. R. A. Hassan, Naoya Kobayashi, Kazuhide Yamamoto, Takeshi Yuasa, Masayuki Seita, Shuhei Nakaji, Eisaku Kondo, Hironobu Kawamoto, Wael A. R. A. Hassan, Yuriko Nishikawa, Toshiyuki Komaki
Publikováno v:
Cell Transplantation, Vol 19 (2010)
Definitive endoderm (DE) derived from stem cells holds potential to differentiate into hepatocytes. Stem cell therapy using those cells has potential for a treatment of liver disease. To date, various ways of inducing hepatocytes from embryonic stem
Autor:
Wael A. R. A. Hassan, Noriaki Tanaka, Eisaku Kondo, Yoshitaka Kondo, Ira J. Fox, Alejandro Soto-Gutierrez, Nalu Navarro-Alvarez, Satoru Kobayashi, Kazuhide Yamamoto, Masaya Iwamuro, Yong Chen, José Caballero-Corbalán, Naoya Kobayashi
Publikováno v:
Journal of hepatology. 52(2)
Background & Aims Transplantation of isolated hepatocytes holds great promise as an alternative to whole organ liver transplantation. For treatment of liver failure, access to the portal circulation has significant risks and intrahepatic hepatocyte e